LinkedIn

Distributors / Reps

Find out how IMDA can help you achieve excellence in specialty sales and marketing.


  Save the Date

IMDA Conference 2018 date coming soon

Meet an IMDA Member - SOTA

 

State of the Art Medical Products
Cedar Grove, N.J.

 


Contact:
Keith Lambie
800-321-7682
KLambie@sotamedical.com

State of the Art (SOTA) Medical Products has been in business for 30+ years.

We are a specialty medical sales and distribution company. SOTA's original sales territory ranged from the New York and Philadelphia metropolitan areas, and now includes all of New England, and goes as far south as Maryland.

Our management team has over 75 years of management, sales and clinical experience. In order to properly support our manufacturers and customers, and provide an integrated sales force within our geographical market.

 SOTA Medical Products has evolved into three separate sales teams servicing three distinct surgical markets:

  1. Advanced Surgical Technologies
  2. Cardiovascular/Interventional Procedures
  3. Surgical Division.

Supporting our sales team is a 7-person, in-house staff located in Cedar Grove, N.J with full logistical functionality

IMDA eNews       1/16/2018

Risk management and medical devices
IMDA members can expect their manufacturer partners and their customers to pay much attention to risk management and medical devices in the year ahead. The Working Group responsible for updating ISO 14971 is expected to release a proposed revision of the standard this spring, with an emphasis on cybersecurity, usability and human factors.

 Hospitals reduce healthcare-associated infections
Hospitals reduced central line-associated bloodstream infections by 50 percent between 2008 and 2016, according to the
Centers for Disease Control and Prevention, reports AHA Today. Hospitals are also making progress in reducing catheter-associated urinary tract, surgical site, methicillin-resistant staphylococcus aureus and Clostridium difficile infections.

What's new?
Some cool medical innovations featured at the recent Consumer Electronics Show in Las Vegas, per MD+DI:

  •  The BoneTag, developed by a France-based team, is used to trace and identify problems associated with orthopedic implants. It plugs directly into the implant and contains an RFID antenna that allows providers to identify the implant from outside the body. It also contains pressure and temperature sensors, which can detect signs of infection, inflammation and movement.
    French company

  • Diabeloop is one of a number of companies pursuing artificial pancreas technology. The company's solution uses a Bluetooth-connected continuous glucose sensor to monitor the patient's glycemia and send data to a smartphone-based app, where it is analyzed by an algorithm that controls delivery of insulin by a connected patch pump. 

  • Focused ultrasound is a noninvasive procedure that harnesses magnetic resonance imaging and focused ultrasound energy to target and treat a host of maladies, ranging from neurological and cardiovascular problems to cancer. The technology uses intersecting beams of energy to ablate tissue, disrupt cell growth, ramp up the immune system and deliver drugs.

The limits of AI
Artificial intelligence many have many applications in healthcare-clinical and administrative (identifying fraud, waste and abuse), but it can't address the core issues of what drives healthcare costs, said Andy Slavitt, former acting administrator of the Centers for Medicare and Medicaid Services, at the recent J.P. Morgan Health Conference in San Francisco. "Someone with diabetes, if they have a nutrition or housing issue, it costs 65 percent more to treat them,"Slavitt was quoted as saying by MedCity News. "Someone with acute behavioral issues, who lives in extreme poverty and has an underlying disease, costs more to treat. How do we solve that problem with science?"